ConductScience.org, home

Paper20445751

Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphoma.

Iurescia S and 7 others. J Biomed Biotechnol, 2010. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphoma. Papers, record 20445751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20445751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphoma.
PubMed
Journal
J Biomed Biotechnol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.33
iCite
Revised in PubMed
2021-10-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iurescia SSandra
2Fioretti DDaniela
3Pierimarchi PPasquale
4Signori EEmanuela
5Zonfrillo MManuela
6Tonon GGiancarlo
7Fazio VMVito M
8Rinaldi MMonica

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complementarity Determining RegionsMajor topic
Lymphoma, B-CellMajor topic
Peptide FragmentsMajor topic
Tetanus ToxinMajor topic
Vaccines, DNAMajor topic
Animals
CD8-Positive T-Lymphocytes
Chi-Square Distribution
Electroporation
Flow Cytometry
Interferon-gamma
Kaplan-Meier Estimate
Male
Mice
Mice, Inbred C3H
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111861263Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients.Blood2002https://conductscience.org/library/papers/11861263PubMed
29129015Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.Blood1997https://conductscience.org/library/papers/9129015PubMed
318364239Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model.Biochem Biophys Res Commun2008https://conductscience.org/library/papers/18364239PubMed
417906339Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition.Int Immunol2007https://conductscience.org/library/papers/17906339PubMed
517878373In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells.J Immunol2007https://conductscience.org/library/papers/17878373PubMed
616860659Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines.Adv Cancer Res2006https://conductscience.org/library/papers/16860659PubMed
710096292Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.Nat Biotechnol1999https://conductscience.org/library/papers/10096292PubMed
88564842Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.Nat Med1996https://conductscience.org/library/papers/8564842PubMed
918781156DNA vaccines: ready for prime time?Nat Rev Genet2008https://conductscience.org/library/papers/18781156PubMed
1011718453Anti-lymphoma immunity: relative efficacy of peptide and recombinant DNA vaccine.Cancer Detect Prev2001https://conductscience.org/library/papers/11718453PubMed
1114974761Cancer statistics, 2004.CA Cancer J Clin2004https://conductscience.org/library/papers/14974761PubMed
128782465DNA immunization induces protective immunity against B-cell lymphoma.Nat Med1996https://conductscience.org/library/papers/8782465PubMed
1315623607Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.Clin Cancer Res2004https://conductscience.org/library/papers/15623607PubMed
1411245465
Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Cancer Res2001https://conductscience.org/library/papers/11245465PubMed
1511466377DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines.J Immunol2001https://conductscience.org/library/papers/11466377PubMed
163498771Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.J Immunol1987https://conductscience.org/library/papers/3498771PubMed
172481588Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.Eur J Immunol1989https://conductscience.org/library/papers/2481588PubMed
1816827622Therapeutic lymphoma vaccines: importance of T-cell immunity.Expert Rev Vaccines2006https://conductscience.org/library/papers/16827622PubMed
1912477501IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains.Dev Comp Immunol2003https://conductscience.org/library/papers/12477501PubMed
2015146248Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.J Clin Invest2004https://conductscience.org/library/papers/15146248PubMed

See all 45 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
35745675Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35745675PubMed
30962578Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies.Leukemia2019https://conductscience.org/library/papers/30962578PubMed
23162790Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins.Front Oncol2012https://conductscience.org/library/papers/23162790PubMed
20390416DNA vaccination strategies for anti-tumour effective gene therapy protocols.Cancer Immunol Immunother2010https://conductscience.org/library/papers/20390416PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDR38163PubTator's text mininghttps://conductscience.org/library/genes/8163NCBI Gene
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20445751

GET https://conductscience.org/api/papers/v1/20445751/references?page=2